Shanghai RAAS Blood Products Co., Ltd. (SHE:002252)
China
· Delayed Price · Currency is CNY 6.24
0.00 (0.00%)
Mar 10, 2026, 12:45 PM CST
SHE:002252 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 41,213 | 47,685 | 53,164 | 42,737 | 45,972 | 49,882 | Upgrade
|
| Market Cap Growth | -11.86% | -10.30% | 24.40% | -7.04% | -7.84% | 35.14% | Upgrade
|
| Enterprise Value | 42,114 | 43,990 | 48,939 | 39,357 | 42,858 | 47,631 | Upgrade
|
| Last Close Price | 6.24 | 7.17 | 7.87 | 6.21 | 6.65 | 7.19 | Upgrade
|
| PE Ratio | 22.68 | 21.74 | 29.88 | 22.73 | 35.51 | 37.68 | Upgrade
|
| Forward PE | 18.49 | 96.49 | 96.49 | 96.49 | 96.49 | 96.49 | Upgrade
|
| PS Ratio | 5.18 | 5.83 | 6.68 | 6.51 | 10.72 | 18.06 | Upgrade
|
| PB Ratio | 1.26 | 1.49 | 1.79 | 1.48 | 1.78 | 1.99 | Upgrade
|
| P/TBV Ratio | 1.75 | 1.81 | 2.19 | 1.79 | 2.21 | 2.53 | Upgrade
|
| P/FCF Ratio | - | - | 29.10 | 28.49 | 42.20 | 54.39 | Upgrade
|
| P/OCF Ratio | - | - | 23.34 | 24.77 | 35.53 | 42.68 | Upgrade
|
| PEG Ratio | 3.70 | 2.29 | 2.29 | 2.29 | 2.29 | 2.29 | Upgrade
|
| EV/Sales Ratio | 5.30 | 5.38 | 6.15 | 5.99 | 10.00 | 17.25 | Upgrade
|
| EV/EBITDA Ratio | 20.80 | 19.19 | 19.76 | 18.14 | 26.52 | 40.63 | Upgrade
|
| EV/EBIT Ratio | 23.47 | 21.02 | 21.13 | 19.79 | 29.31 | 46.71 | Upgrade
|
| EV/FCF Ratio | -70.34 | - | 26.79 | 26.24 | 39.34 | 51.94 | Upgrade
|
| Debt / Equity Ratio | 0.09 | 0.00 | 0 | 0 | 0 | 0 | Upgrade
|
| Debt / EBITDA Ratio | 1.48 | 0.01 | 0.00 | 0.00 | 0.01 | 0.01 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.00 | 0.00 | 0.01 | 0.01 | Upgrade
|
| Net Debt / Equity Ratio | 0.03 | -0.09 | -0.14 | -0.15 | -0.11 | -0.09 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.45 | -1.29 | -1.69 | -1.94 | -1.83 | -1.88 | Upgrade
|
| Net Debt / FCF Ratio | -1.50 | 3.34 | -2.30 | -2.81 | -2.71 | -2.41 | Upgrade
|
| Asset Turnover | 0.22 | 0.25 | 0.26 | 0.23 | 0.16 | 0.15 | Upgrade
|
| Inventory Turnover | 1.16 | 1.22 | 1.37 | 1.14 | 0.78 | 0.52 | Upgrade
|
| Quick Ratio | 1.74 | 2.90 | 2.22 | 3.16 | 2.77 | 8.47 | Upgrade
|
| Current Ratio | 3.37 | 5.61 | 3.87 | 5.22 | 5.26 | 15.18 | Upgrade
|
| Return on Equity (ROE) | 5.73% | 7.12% | 6.08% | 6.85% | 5.05% | 7.20% | Upgrade
|
| Return on Assets (ROA) | 3.14% | 3.99% | 4.64% | 4.31% | 3.47% | 3.41% | Upgrade
|
| Return on Invested Capital (ROIC) | 4.53% | 6.44% | 7.46% | 6.89% | 5.34% | 5.57% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.10% | 6.50% | 7.80% | 6.90% | 5.60% | 4.10% | Upgrade
|
| Earnings Yield | 4.43% | 4.60% | 3.35% | 4.40% | 2.82% | 2.65% | Upgrade
|
| FCF Yield | -1.45% | -1.86% | 3.44% | 3.51% | 2.37% | 1.84% | Upgrade
|
| Dividend Yield | 0.49% | 0.98% | 0.38% | 0.48% | 0.42% | 0.35% | Upgrade
|
| Payout Ratio | 12.26% | 20.05% | 11.36% | 10.04% | 13.02% | 5.12% | Upgrade
|
| Buyback Yield / Dilution | -1.73% | -0.84% | 2.23% | - | -5.28% | -26.40% | Upgrade
|
| Total Shareholder Return | -1.24% | 0.13% | 2.61% | 0.48% | -4.86% | -26.05% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.